Research coauthored by RTI Health Solutions researchers will be presented at the 2023 Canadian Immunization Conference.
Cost-effectiveness and public health impact of recombinant zoster vaccine in immunocompromised adults in Canada. George S, Carrico J, Hicks K, Loukov D, Ng C, Kaan I, Curran D. Poster
